The relationship between the two organisations aims to add value to the process of prescribing medicines, providing up-to-date information according to the specific characteristics of the country in which they are located and benefiting patient safety.
Santiago de Chile, September 2021 - In recent years, public and private health services have become aware of the need to integrate technology into their processes in order to make better clinical decisions, optimise costs, increase clinical safety and improve the continuum of patient care throughout the health network. In this context, InterSystems, a data technology provider dedicated to solving critical information problems, has implemented the unified health information system, InterSystems TrakCare, at RedSalud. At the same time, VIDAL Vademecum was incorporated as a source of pharmacological information and clinical decision support for drug prescribing.
In fact, the alliance guarantees the quality of care for RedSalud patients, regardless of the care centre in which they are located. In this way, the professional will be able to anticipate possible drug interactions and/or adverse effects related to the specific pathophysiological characteristics of the patient.
"At InterSystems, we offer the best services according to the needs of each of our customers, and this type of solution has advantages for both patients and healthcare professionals," says Martin Kozak, Country Manager for InterSystems Chile.
Paul Bonnet, General Manager for Latin America and Spain at VIDAL Vademecum International, explains that what generated the integration of Vidal Vademecum in the prescription workflow in TrakCare "is the ability to make available drug information in Chile in a structured and constantly updated way, as well as to provide the prescriber with a risk assessment that helps him or her make the best decision for the safety of his or her patients.
The alliance established between Intersystems and VIDAL Vademecum, on the occasion of the implementation of the TrakCare system, its unified health information system, aims to allow health professionals to have access to information on the country's medicines, their formats, their dosage, among others. It also provides alerts on drug interactions, taking into account the pathophysiological characteristics of patients, integrating it into their normal workflow, supporting decision making and anticipating possible medication errors. This results in an active process of quality assurance and clinical safety for patients. Translated with www.DeepL.com/Translator (free version)
**About InterSystems** Founded in 1978, InterSystems is a leading provider of technology for mission-critical systems in the healthcare, financial, manufacturing and supply chain industries. Its cloud-based data platforms solve interoperability, speed and scalability challenges for large organisations around the world. InterSystems also develops and supports managed services for hospital electronic clinical records, unified care records for communities and nations, and laboratory information management systems. InterSystems is committed to excellence through its award-winning 24×7 support for customers and partners in over 80 countries. Privately held and headquartered in Cambridge, Massachusetts, InterSystems has 25 offices worldwide. For more information, visit InterSystems.com/cl.
About VIDAL Vademecum
Part of the VIDAL Group based in Paris, France (since 1914), VIDAL Vademecum provides healthcare product information, therapeutic decision support and patient record management solutions to continuously improve medical practices. With a fully multilingual knowledge base and teams in France, Germany, Spain, Mexico and Chile, VIDAL Vademecum is the leading European player in the field of medical informatics and artificial intelligence applied to healthcare. The group markets its solutions in 30 countries around the world; in Europe, they are used by more than 700,000 healthcare professionals. In 2016, VIDAL Group joined the M3 group, a global player in digital health and a leader in Asia and Japan. M3 is listed on the Tokyo Stock Exchange (2413.T).
Press contact InterSystems
Camila Magliona +56978647499
Account Manager / e-press
Joaquín Guzmán Meneses +56 9 9820 4887
Director / e-press